About Archimica
Archimica is a company based in Sandycroft (United Kingdom) founded in 1999 was acquired by PI Health Sciences in April 2023. Archimica offers products and services including Cytarabine, Hydroxyurea, and Mianserin. Archimica operates in a competitive market with competitors including Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others.
- Headquarter Sandycroft, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Archimica S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Euticals
& 1 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Archimica
Archimica offers a comprehensive portfolio of products and services, including Cytarabine, Hydroxyurea, and Mianserin.
Nucleoside analogue for cancer treatment applications
Modified urea used in medical therapies
Tetracyclic compound for pharmaceutical purposes
Funding Insights of Archimica
Investors in Archimica
Archimica has secured backing from 2 investors. Prominent investors backing the company include Euticals and PI Health Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Specializes in CRO and CDMO services for medicinal chemistry and API manufacturing.
|
Founded Year | Domain | Location | |
|
APIs, custom synthesis, and fine chemicals are developed and manufactured.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Archimica
Financial Statements - Archimica
Archimica Comparisons
Competitors of Archimica
Archimica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neogen, Parse Biosciences, Qiagen, Biofidelity and Fluent BioSciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing
|
|
| domain | founded_year | HQ Location |
RNA-sequencing transcriptome kits for health data analysis are developed.
|
|
| domain | founded_year | HQ Location |
Products and reagents for molecular diagnostic assays are supplied.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostic assays are developed for target DNA sequence detection.
|
|
| domain | founded_year | HQ Location |
Proprietary reagents for single-cell genetic analysis are developed.
|
|
| domain | founded_year | HQ Location |
Digital PCR solutions for research are developed and analyzed.
|
Frequently Asked Questions about Archimica
Archimica was founded in 1999.
Archimica is headquartered in Sandycroft, United Kingdom.
Norbert Dieterich is the current CEO of Archimica.
Archimica was established in 1999 in Sandycroft, United Kingdom, within the biotechnology sector focused on molecular diagnostics. Nucleic acid analysis tools are created for research and clinical use, including next-generation real-time polymerase chain reaction systems. Operations center on advancing diagnostic technologies, with the company accessible via archimica.com. Leadership is provided by CEO Norbert Dieterich, supporting applications in healthcare and scientific research.
Archimica's top competitors include Neogen, Stilla Technologies and Qiagen.
Archimica offers Cytarabine, Hydroxyurea, and Mianserin.
Archimica has 2 investors. Key investors include Euticals, and PI Health Sciences.